ANN ARBOR, MI, Oct. 10, 2023 – Akadeum Life Sciences, the global leaders in buoyancy-based cell separation technology, have announced today the preview of their AlerionTM cell separation system. The instrument will provide a closed system for separating T cells from a leukopak using Akadeum’s revolutionary Buoyancy Activated Cell Sorting (BACS™) microbubble technology. The instrument promises to [...]
Akadeum Life Sciences, a global leader in buoyancy-based cell separation and activation technology, is announcing the launch of a new series of products for cell therapy research and development—enabling direct leukopak human immune cell isolation and T-cell activation/expansion kits at the American Society of Gene + Cell Therapy's 26th Annual Meeting from May 16-20, 2023 [...]
ANN ARBOR, Mich., Dec. 21, 2022 (GLOBE NEWSWIRE) -- Akadeum Life Sciences, Inc., a global leader in buoyancy-based cell separation technology, announces their Microbubble Leukopak Human T Cell Isolation research-use-only kit that resulted from successful external user data with early adopters. Akadeum’s T cell isolation kit is an industry first to incorporate Buoyancy Activated Cell Sorting [...]
Akadeum Life Sciences has scored a patent for its method of buoyancy-based cell sorting (BACS) technologies from biological fluid samples. The Ann Arbor, MI-based firm says the use of microbubbles are used to separate targeted cell groups. Most notably, the patent protects Akadeum's T and B Cell isolation kits along with its entire portfolio of [...]
Akadeum is thrilled to announce the first recipient of the Rising Innovators Research Award! Congratulations to Giselle Borges e Soares from Dr. Katherine Wall’s Laboratory at the University of Toledo. Giselle used Akadeum’s Mouse CD4+ T Cell Isolation Kit in the course of her research, obtaining 95-97% purity with ease. The success of downstream experiments is dependent upon the quality [...]
October 12, 2021, Ann Arbor, MI – Akadeum Life Sciences, Inc., today announced the closing of an oversubscribed $17.5 million Series B financing led by Arboretum Ventures. Investors in the round also included Beringea, Agilent Technologies (NYSE:A), Lifespan Ventures, BlueStone Venture Partners, Berkeley Catalyst Fund, Michigan Capital Network, Michigan Rise, The University of Michigan, and others. [...]
Biological samples are incredibly diverse and complex, and an initial cleanup step is essential to reduce sample heterogeneity prior to downstream applications. This is especially important when dealing with cell types of low abundance like Invariant natural killer T (iNKT) cells. iNKT cells are a subset of unconventional T cells that recognize lipid-based antigens and [...]
ANN ARBOR, Mich., June 10, 2020 /PRNewswire/ -- Akadeum Life Sciences, Inc., creators of a next generation floatation-based isolation platform, and NanoCellect Biomedical, Inc., a leader in the development and manufacturing of innovative and simple solutions for cell sorting, today jointly announced a new collaboration to improve rare-cell workflows. From single cell genomics to antibody discovery, researchers increasingly [...]
Akadeum is pleased to announce that we are a semi-finalist in the XPRIZE Rapid Covid Testing competition. We have recently expanded our microbubble platform by functionalizing our revolutionary buoyancy-activated separation technology for RNA isolation in saliva samples. Our goal is to create a workflow that allows for quick and easy RNA extraction in larger volume [...]
The coronavirus pandemic has highlighted a need for fast and accurate methods for identifying RNA viruses through nucleic acid capture and detection. Akadeum Life Sciences is up to the challenge. In a relatively short time, the coronavirus pandemic has spread across the globe. This novel virus was first noted in Wuhan, China in December 2019 [...]
Akadeum Life Sciences, Inc. announced an initial close of its Series A financing. The company is pursuing additional investment before final close during Q1 2020. These funds will enable Akadeum to focus its commercial adoption on how to solve longstanding problems in sample preparation. The investment includes several Michigan-based angel groups in addition to venture [...]
Akadeum Life Sciences, Inc., an Ann Arbor-based biotechnology company, announced today that it has entered into a collaboration with Agilent Technologies, Inc. to work toward a new method of isolating target molecules for detection. Akadeum aims to disrupt the status quo in isolation technology with their buoyant microbubbles. Notably, Akadeum is the first company to [...]
Ann Arbor-based biotech company, Akadeum Life Sciences, announced the release of seven new products based on its proprietary microbubble technology. Akadeum Life Sciences today announced at Immunology 2019 the introduction of its first suite of products based on its microbubble technology. Unlike magnetic-based products, microbubbles use buoyancy to gently separate cells of interest within the [...]
Ann Arbor-based biotech company, Akadeum Life Sciences, announced the release of seven new products based on its proprietary microbubble technology. Akadeum Life Sciences today announced at Immunology 2019 the introduction of its first suite of products based on its microbubble technology. Unlike magnetic-based products, microbubbles use buoyancy to gently separate cells of interest within the [...]
ANN ARBOR, MICH. (PRWEB) SEPTEMBER 06, 2018 Akadeum Life Sciences today announced it has appointed George Dunbar to its Board of Directors. Dunbar has spent his career as an executive and leader of numerous biotech companies. He most recently served as president and CEO of ISTO Biologics, a private cell therapy and biologics company acquired [...]
ANN ARBOR, MICH. (PRWEB) AUGUST 28, 2018 Akadeum Life Sciences, Inc. has announced early access to its microbubble-based T cell and B cell isolation kits. A radical simplification over existing technologies, the use of microbubbles enables users to perform the entire cell separation process within a single tube and without a magnet. The company has [...]
Silicon Valley investors have led a funding round of almost $1.5 million in Ann Arbor-based Akadeum Life Sciences Inc., a spinoff from the University of Michigan, to develop its technology for tissue, water and food testing. The lead investor, BioInfleXion Point Partners, specializes in early-stage life-science investments. The round was joined by other Silicon Valley [...]
ANN ARBOR, MICHIGAN (PRWEB) AUGUST 08, 2017 Each year, the top minds in cytometry—which refers to the methodology used to extract quantitative information from individual cells—join together at ISAC’s CYTO Innovation to present the industry’s new technologies in the technology showcase. This year, Ann Arbor-based Akadeum Life Science, Inc.’s microbubble technology rose to the top [...]
Featured in The Huffington Post on 03/01/2016: Read full article Akadeum Life Sciences’ CEO (Brandon McNaughton) recently sat down for a discussion on Sirius XM with Steve Blank. Steve interviewed Brandon as part of Entrepreneurs are Everywhere. They discussed topics ranging from cell separation with microbubbles to figuring out how to move an idea from an idea to sales. See below [...]
“Clinician-scientist John Younger went one step further than a leave of absence. After partially sidelining his 21-year career in emergency medicine at the University of Michigan (UM), Ann Arbor, in 2014 to develop a micro-bubble cell-capturing technology, he ended up leaving academia completely. ” … “The initial idea was to use tiny spheres tagged with [...]
"Cell isolation technologies are becoming more and more important. Everyone is looking for easy, simple, low cost, and this promises to take care of all three. As far as early-stage technologies go, this is as promising as I've ever seen" -Bill Hyun (Director of the Laboratory for Advanced Cytometry at the University of California, San [...]
Akadeum Life Sciences is doing something that most biotechs don’t, says CEO Brandon McNaugton: practicing the lean startup method, which puts a heavy focus on customer discovery and feedback. It was this process of talking to customers that inspired Ann Arbor, MI-based Akadeum to develop the Application Discovery Program, a tool it uses to help customers with [...]
From blood to food to medicine, cells are all around us. However, the current methods of separating those cells from their surroundings for research, diagnostics, and cell therapy--also known as cell sorting--can be time-consuming, costly, and damaging to the cells. To address this, Ann Arbor-based startup Akadeum Life Sciences is developing a radically new product that uses [...]
Akadeum Life Sciences just landed a six-figure seed capital round. The $150,000 raise was led by Ann Abror-based venture capital firm Michigan eLab. "They are wicked smart entrepreneurs doing something really hard that will have a big impact on the world," says Doug Neal, managing director of Michigan eLab. "Those three criteria are really important to [...]
Michigan eLab has made its first local investment in Akadeum Life Sciences LLC, a startup that hopes to make it easier, cheaper and faster to prepare tissue, water or food samples for testing